Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,690,355
-
Total 13F shares
-
166,602,554
-
Share change
-
-5,310,680
-
Total reported value
-
$2,094,673,928
-
Price per share
-
$12.58
-
Number of holders
-
205
-
Value change
-
-$62,666,606
-
Number of buys
-
91
-
Number of sells
-
106
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q1 2022
As of 31 Mar 2022,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by
205 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
166,602,554 shares.
The largest 10 holders included
Sarissa Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., BROWN CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, STATE STREET CORP, LSV ASSET MANAGEMENT, PUTNAM INVESTMENTS LLC, and CREDIT SUISSE AG/.
This page lists
205
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.